|
|
Tel: 033-4017-0500
|
|
Tel: 2290-4706
|
|
 |
|
|
Aristro Capital Markets Ltd. |
|
|
|
|
|
|
|
You Are On : Home | Equity |
Company Profile | Company Background
|
|
|
|
|
|
|
|
|
Company Background
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Sequent |
|
BSE Code |
512529
|
|
ISIN Demat |
INE807F01027
|
|
Book Value (Rs.) |
46.71
|
|
|
NSE Code |
SEQUENT
|
|
Dividend Yield % |
0.00
|
|
Market Cap (Rs. Mn) |
50804.88
|
|
|
TTM PE (x) |
376.61
|
|
TTM EPS (Rs.) |
0.53
|
|
Face Value (Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
28-06 1985
|
|
Registered Office
|
3rd Floor, Srivalli’s Corporate,Plot No. 290, S Y N 33 34 P To 39,Guttala Begumpet, Jubilee Hills, Hyderabad, Telangana-500033 .
|
|
ISINNO
|
INE807F01027
|
|
Phone
|
9391139986
|
|
E-mail
|
investorrelations@sequent.in |
|
URL
|
www.sequent.in |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Kamal K Sharma
|
|
Managing Director
|
Rajaram Narayanan
|
|
Company Secretary
|
Yoshita Vora
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|
|
|